• 1
    Vane JR: Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature (New Biol) 231: 232235, 1971
  • 2
    Atkinson DC, Collier HOJ: Salicylates: molecular mechanism of therapeutic action. Adv Pharmacol Chemother 17: 233288, 1980
  • 3
    Estes D, Kaplan K: Lack of platelet effect with the aspirin analog, salsalate. Arthritis Rheum 23: 13031307, 1980
  • 4
    Morris HG, Sherman NA, McQuain C, Goldlust MB, Chang SF, Harrison L: Effects of salsalate (nonacetylated salicylate) and aspirin on serum prostaglandins in humans. Ther Drug Monit 7: 435438, 1985
  • 5
    Zurier RB, Quagliata F: Effect of prostaglandin E1 on adjuvant arthritis. Nature 234: 304305, 1971
  • 6
    Zurier RB, Ballas M: Prostaglandin E1 (PGE1) suppression of adjuvant arthritis: histopathology. Arthritis Rheum 16: 251258, 1973
  • 7
    Tateson JE, Moncada S, Vane JR: Effects of prostacyclin (PGX) on cyclic AMP concentrations in human platelets. Prostaglandins 13: 389399, 1977
  • 8
    Weissmann G, Dukar P, Zurier RB: Effect of cyclic AMP on release of lysosomal enzymes from phagocytes. Nature (New Biol) 231: 131135, 1971
  • 9
    Weksler BB, Knapp JM, Jaffe EA: Prostacyclin (PGI2) synthesized by cultured endothelial cells modulates polymorphonuclear leukocyte function (abstract). Blood 50(suppl 1): 287, 1977
  • 10
    Lombardino J, Otternes I, Wiseman E: Acidic antiinflammatory agents. Arzneimittelforschung 25: 16291634, 1975
  • 11
    Biemond P, Swaak AG, Penders JA, Beindroff CM, Koster JF: Superoxide production by polymorphonuclear leucocytes in rheumatoid arthritis and osteo-arthritis: in vivo inhibition by the antirheumatic drug piroxicam due to interference with the activation of the NADPH-oxidase. Ann Rheum Dis 45: 249255, 1986
  • 12
    Bomalaski JS, Hirata F, Clark M: Aspirin inhibits phospholipase C. Biochem Biophys Res Commun 139: 115121, 1986
  • 13
    Siegel M, McConnell R, Cuatrecasas P: Aspirin-like drugs interfere with arachidonate metabolism by inhibition of the 12-hydroperoxy-5,8,10,14-eicosa-tetracerioic acid peroxidase activity of the lipoxygenase pathway. Proc Natl Acad Sci USA 76: 37743778, 1979
  • 14
    Miyahara JT, Karler R: Effect of salicylate on oxidative phosphorylation and respiration of mitochondrial fragments. Biochem J 97: 194198, 1965
  • 15
    Bomalaski JS, Alvarez J, Touchstone J, Zurier RB: Alteration of uptake and distribution of eicosanoid precursor fatty acids by aspirin. Biochem Pharmacol 36: 32493253, 1987
  • 16
    Lucas-Heron B, Fontenaille C: Urate transport in human red blood cells: activation by ATP. Biochim Biophys Acta 553: 284294, 1979
  • 17
    Kim C, Tuama LA, Mann JD, Roe CR: Saturable accumulation of the anion herbicide 2,4 dichlorophen-oxyacetic acid by rabbit choroid plexus: early developmental origin and interaction with salicylates. J Pharmacol Exp Ther 225: 699704, 1983
  • 18
    Snow IB, Maass AR: Renal sites of natriuretic and uricosuric activity of ticrynafen in the mongrel dog. Nephron 23: 1520, 1979
  • 19
    Famaey J-P, Brooks PM, Carson Dick W: Biological effects of non-steroidal anti-inflammatory drugs. Semin Arthritis Rheum 5: 6381, 1975
  • 20
    Greiling H, Gressner AM, Stuhlsatz HW: Influence of anti-inflammatory drugs on connective tissue metabolism, Experimental Models of Chronic Inflammatory Diseases. Edited by LEGlynn, HDSSchlumberger. Berlin, Springer-Verlag, 1977
  • 21
    Arumugham R, Bose SM: Effect of indomethacin and naproxen on the metabolism of glycosaminoglycans. Scand J Rheumatol 11: 225229, 1982
  • 22
    Palmoski MJ, Brandt KD: Effect of salicylate on proteoglycan metabolism in normal canine articular cartilage in vitro. Arthritis Rheum 22: 746754, 1979
  • 23
    Herman JH, Appel AM, Khosia RC, Kelch BS, Hess EV: Cytokine modulation of chondrocyte metabolism: in vivo and in vitro effects of piroxicam. Inflammation 8: 51255137, 1984
  • 24
    Palmoski MJ, Brandt KD: Effects of some nonsteroidal antiinflammatory drugs on proteoglycan metabolism and organization in canine articular cartilage. Arthritis Rheum 23: 10101020, 1980
  • 25
    Weissmann G, Smolen JE, Korchak HM: Release of inflammatory mediator from stimulated neutrophils. N Engl J Med 303: 2734, 1980
  • 26
    Berridge MJ, Irvine RF: Inositol trisphosphate: a novel second messenger in cellular signal transduction. Nature 312: 315317, 1984
  • 27
    Nishizuka Y: The role of protein kinase C in cell surface signal transduction. Nature 308: 693698, 1984
  • 28
    Smith CD, Lefkowitz RJ, Snyderman R: Guanine nucleotides modulate the binding affinity of the oligonucleotide chemoattractant receptor on human polymorphonuclear leukocytes. J Clin Invest 72: 748753, 1983
  • 29
    Smith CD, Cox CL, Snyderman R: Receptor coupled activation of phosphoinositide-specific phospholipase C by an N protein. Science 232: 97100, 1980
  • 30
    Korchak HM, Rutherford LE, Weissmann G: Stimulus response coupling in human neutrophil. I. Kinetic analysis of changes in calcium permeability. J Biol Chem 259: 40704075, 1984
  • 31
    Smolen JE, Korchak HM, Weissmann G: Initial kinetics of lysosomal enzyme secretion and superoxide anion generation by human polymorphonuclear leukocytes. Inflammation 4: 145163, 1980
  • 32
    Hoffstein S: Ultrastructural demonstration of calcium loss from local regions of the plasma membrane of surface-stimulated human granulocytes. J Immunol 123: 13941402, 1979
  • 33
    Naccache PH, Showell HJ, Becker EL, Sha'afi RI: Involvement of membrane calcium in the response of rabbit neutrophils to chemotactic factors as evidenced by the fluorescence of chlorotetracycline. J Cell Biol 83: 179186, 1979
  • 34
    Abramson S, Edelson H, Kaplan H, Ludewig R, Weissmann G: Inhibition of neutrophil activation by nonsteroidal antiinflammatory drugs. Am J Med 77(suppl 4B): 36, 1984
  • 35
    Abramson S, Korchak HM, Ludewig R, Edelson H, Haines K, Levin R, Herman R, Rider L, Kimmel S, Weissmann G: Modes of action of aspirin-like drugs. Proc Natl Acad Sci USA 82: 72277231, 1985
  • 36
    Walker J, Smith M, Ford-Hutchinson AW: Anti-inflammatory drugs, prostaglandins and leukocyte migration. Agents Actions 6: 602606, 1976
  • 37
    Hopkins NK, Lin A, Groman R: Evidence for mediation of acetyl glycerol ether phosphorylcholine stimulation of adenosine 5′-(cyclic) monophosphate levels in human polymorphonuclear leukocytes by leukotriene B4. Bio-chim Biophys Acta 763: 276283, 1983
  • 38
    Simchowitz L, Mehta J, Spilberg I: Chemotactic factor-induced generation of superoxide radicals by human neutrophils: effect of metabolic inhibitors and antiinflammatory drugs. Arthritis Rheum 22: 755763, 1979
  • 39
    Perez HD, Elfman F, Marder S: Meclofenamate sodium monohydrate inhibits chemotactic factor–induced human polymorphonuclear leukocyte function: a possible explanation for its antiinflammatory effect. Arthritis Rheum 30: 10231031, 1987
  • 40
    Minta JO, Williams MD: Some nonsteroidal antiinflammatory drugs inhibit the generation of superoxide anions by activated polymorphs by blocking ligand-receptor interactions. J Rheumatol 12: 751757, 1985
  • 41
    Kaplan H, Edelson H, Korchak H, Given W, Abramson S, Weissmann G: Effects of non-steroidal anti-inflammatory agents on human neutrophil functions in vitro and in vivo. Biochem Pharmacol 33: 371378, 1984
  • 42
    Van Epps DE, Greiwe S, Potter J, Goodwin J: Alterations in neutrophil superoxide production following piroxicam therapy in patients with rheumatoid arthritis. Inflammation 11: 5972, 1986
  • 43
    Montecucco C, Mazzone A, Pasotti D, Fratino P: Effect of piroxicam therapy on granulocyte function elastase concentration in peripheral blood and synovial fluid in rheumatoid arthritis patients. Inflammation (in press)
  • 44
    Smith JB, Willis AL: Aspirin selectively inhibits prostaglandin production in human platelets. Nature (New Biol) 231: 235237, 1971
  • 45
    Koo C, Lefkowitz RJ, Snyderman R: Guanine nucleotides modulate the binding affinity of the oligopeptide chemoattractant receptor on human polymorphonuclear leukocytes. J Clin Invest 72: 748753, 1983
  • 46
    Yuli I, Tomonaga A, Snyderman R: Chemoattractant receptor functions in human polymorphonuclear leukocytes are divergently altered by membrane fluidizers. Proc Natl Acad Sci USA 79: 59065910, 1982
  • 47
    Abramson S, Haines K, Leszczynska J, Reibman J, Weissmann G: Nonsteroidal antiinflammatory drugs inhibit neutrophil (PMN) functions via effects at the G protein of the plasma membrane (abstract). Clin Res 36: 548A, 1988
  • 48
    Weissmann G, Vosshall LB, Bayer CA, Dunham PB: Marine sponge aggregation: a model for effects of NSAIDs on the calcium movements of cell activation. Semin Arthritis Rheum 15: 4253, 1985